ATP Citrate Lyase Inhibitors |
|
Cat. No. |
Product |
Activity |
4609 |
BMS 303141 |
ATP citrate lyase
inhibitor; orally bioavailable |
4962 |
SB 204990 |
ATP citrate lyase
(ACLY) inhibitor |
|
|
|
Fatty
Acid Binding Proteins (FABP) Inhibitors |
|
Cat. No. |
Product |
Activity |
1570 |
(-)-Cannabidiol |
FABP inhibitor;
inhibits Anandamide uptake; natural cannabinoid |
1116 |
AM 404 |
FABP inhibitor;
also Anandamide transport inhibitor and TRPV agonist |
5258 |
BMS 309403 |
Potent and
selective FABP4 inhibitor |
|
|
|
Fatty
Acid Synthase Inhibitors |
|
Cat. No. |
Product |
Activity |
2489 |
C 75 |
Potent fatty acid
synthase inhibitor; proapoptotic |
5446 |
G 28UCM |
FASN inhibitor |
5303 |
GSK 2194069 |
Potent human fatty
acid synthase (hFASN) inhibitor |
3540 |
Orlistat |
Inhibits the
thioesterase domain of fatty acid synthase; also carboxylester lipase
inhibitor |
|
|
|
Lysosomal
Acid Lipase Inhibitors |
|
Cat. No. |
Product |
Activity |
6098 |
Lalistat 1 |
Potent and
selective LAL inhibitor |
6099 |
Lalistat 2 |
Selective LAL
inhibitor |
|
|
|
Stearoyl-CoA
9-Desaturase Inhibitors |
|
Cat. No. |
Product |
Activity |
4845 |
A 939572 |
Potent SCD-1
inhibitor |
4847 |
PluriSln 1 |
SCD-1 inhibitor |
|
|
|
Other
Lipid Metabolism Inhibitors |
|
Cat. No. |
Product |
Activity |
0477 |
(±)-Decanoylcarnitine
chloride |
Intermediate in
lipid metabolism |
0605 |
(±)-Octanoylcarnitine
chloride |
Intermediate in
lipid metabolism |
6319 |
CBM 301940 |
Potent malonyl-CoA
decarboxylase inhibitor; orally bioavailable |
6765 |
JTP 103237 |
Potent and
selective monoacyglycerol acyltransferase 2 (MOGAT2) inhibitor |
5631 |
LDN 193188 |
Inhibitor of
phosphatidylcholine transfer protein (PC-TP) |
7492 |
Lomitapide mesylate |
Potent microsomal
triglyceride transfer protein (MTP) inhibitor |
1484 |
Oleylethanolamide |
Lipid mediator,
anorexic actions; also GPR55 and PPARα agonist |
5790 |
PF 05175157 |
Potent acetyl-CoA
carboxylase (ACC) 1 and 2 inhibitor |
1842 |
RHC 80267 |
Diacylglycerol
lipase inhibitor |
5389 |
Ro 48-8071 fumarate |
2,3-Oxidosqualene
cyclase (OSC) inhibitor; blocks cholesterol synthesis |
4189 |
SC 26196 |
Selective FADS2
inhibitor |
6106 |
T 3364366 |
Potent and
reversible FADS1 inhibitor; orally bioavailable |